-
Publication Venue For
-
Prenatal opioid exposure inhibits microglial sculpting of the dopamine system selectively in adolescent male offspring..
47:1755-1763.
2022
-
Organization of the social cognition network predicts future depression and interpersonal impairment: a prospective family-based study.
47:531-542.
2022
-
Transcriptome-based polygenic score links depression-related corticolimbic gene expression changes to sex-specific brain morphology and depression risk..
46:2304-2311.
2021
-
Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model..
44:245-258.
2019
-
Coordination of Brain-Wide Activity Dynamics by Dopaminergic Neurons..
42:615-627.
2017
-
A Functional Interleukin-18 Haplotype Predicts Depression and Anxiety through Increased Threat-Related Amygdala Reactivity in Women but Not Men..
42:419-426.
2017
-
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse..
42:156-177.
2017
-
Genetic Moderation of Stress Effects on Corticolimbic Circuitry..
41:275-296.
2016
-
Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adults.
40:2745-2752.
2015
-
Stress-system genes and life stress predict cortisol levels and amygdala and hippocampal volumes in children..
39:1245-1253.
2014
-
Enhancement of rTMS Neuromodulatory Effects with Novel Waveforms Demonstrated via Controllable Pulse Parameter TMS (cTMS).
38:S246-S247.
2013
-
Optimizing Stimulus Pulse Characteristics for Transcranial Magnetic Stimulation and Electroconvulsive Therapy via Device Development, Computational Modeling, and Biophysically-motivated Dosing Paradigms.
38:S30-S31.
2013
-
The Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Verbal Learning and Memory.
38:S426-S427.
2013
-
Erratum: Focal electrically administered seizure therapy: A novel form of ECT illustrates the roles of current directionality, polarity, and electrode configuration in seizure induction (Neuropsychopharmacology (2009) 34 (2002-2010) DOI: 10.1038/npp.2009.12).
37:1077.
2012
-
Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity..
36:1940-1947.
2011
-
Fluoxetine Alleviates Behavioral Depression while Decreasing Acetylcholine Release in the Nucleus Accumbens Shell.
36:1729-1737.
2011
-
Acute 5-HT reuptake blockade potentiates human amygdala reactivity..
33:3221-3225.
2008
-
Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues..
33:2148-2157.
2008
-
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial..
33:1217-1228.
2008
-
ACNP White Paper: update on use of antipsychotic drugs in elderly persons with dementia..
33:957-970.
2008
-
Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys..
33:270-278.
2008
-
Imaging genetics offers new predictive markers of individual differences in behavior and risk for psychiatric diseases.
33:201-202.
2008
-
Gender-specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention..
32:2453-2464.
2007
-
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care..
32:2479-2489.
2007
-
Regional brain activity correlates of nicotine dependence..
32:2441-2452.
2007
-
Prefrontal white matter lesions and prefrontal task impersistence in depressed and nondepressed elders..
32:2135-2142.
2007
-
Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at 6 months of age..
32:1082-1097.
2007
-
Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders..
32:257-262.
2007
-
Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors..
32:377-387.
2007
-
Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics..
32:95-102.
2007
-
Prenatal nicotine exposure alters the responses to subsequent nicotine administration and withdrawal in adolescence: Serotonin receptors and cell signaling..
31:2462-2475.
2006
-
Erratum: VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms (Neuropsychopharmacology (2006) 31 (1345-1355) DOI: 10.1038/sj.npp.1301082).
31:2329.
2006
-
Baseline neurocognitive deficits in the CATIE schizophrenia trial..
31:2033-2046.
2006
-
Report by the ACNP Task Force on response and remission in major depressive disorder..
31:1841-1853.
2006
-
The G72/G30 gene complex and cognitive abnormalities in schizophrenia..
31:2022-2032.
2006
-
Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability..
31:1647-1658.
2006
-
Cocaine self-administration reduces excitatory responses in the mouse nucleus accumbens shell..
31:1444-1451.
2006
-
Lobar distribution of lesion volumes in late-life depression: the Biomedical Informatics Research Network (BIRN)..
31:1500-1507.
2006
-
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms..
31:1345-1355.
2006
-
Visuospatial memory deficits emerging during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking..
31:1550-1561.
2006
-
Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics..
31:1249-1263.
2006
-
Sex differences in neurochemical effects of dopaminergic drugs in rat striatum..
31:1193-1202.
2006
-
Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems..
31:904-911.
2006
-
Increased pituitary volume in ...psychosis study..
31:243.
2006
-
Lasting effects of developmental dexamethasone treatment on neural cell number and size, synaptic activity, and cell signaling: critical periods of vulnerability, dose-effect relationships, regional targets, and sex selectivity..
31:12-35.
2006
-
Cortical white matter microstructural abnormalities in bipolar disorder..
30:2225-2229.
2005
-
Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues..
30:1940-1947.
2005
-
Disruption of rat forebrain development by glucocorticoids: critical perinatal periods for effects on neural cell acquisition and on cell signaling cascades mediating noradrenergic and cholinergic neurotransmitter/neurotrophic responses..
30:1841-1855.
2005
-
Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene..
30:1818-1831.
2005
-
Trauma, proximity, and developmental psychopathology: the effects of war and terrorism on children..
30:1781-1792.
2005
-
Erratum: Novelty seeking and stereotypic activation of behavior in mice with disruption of the DatI gene (Neuropsychopharmacology (April 27, 2005), DOI:10.1038/sj.npp.1300724).
30:1772.
2005
-
Gestational dexamethasone treatment elicits sex-dependent alterations in locomotor activity, reward-based memory and hippocampal cholinergic function in adolescent and adult rats..
30:1617-1623.
2005
-
Reversal of clozapine effects on working memory in rats with fimbria-fornix lesions..
30:1121-1127.
2005
-
Comparing the effects of antidepressants: consensus guidelines for evaluating quantitative reviews of antidepressant efficacy..
30:445-460.
2005
-
Medical comorbidity in a bipolar outpatient clinical population..
30:401-404.
2005
-
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients..
30:405-416.
2005
-
Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of rhesus monkeys..
30:129-144.
2005
-
Nicotine therapy in adulthood reverses the synaptic and behavioral deficits elicited by prenatal exposure to phenobarbital..
30:156-165.
2005
-
Serotonergic cell signaling in an animal model of aging and depression: olfactory bulbectomy elicits different adaptations in brain regions of young adult vs aging rats..
30:52-57.
2005
-
A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future..
29:2285-2299.
2004
-
Is there a definition of remission in late-life depression that predicts later relapse?.
29:2272-2277.
2004
-
Prefrontal neuropsychological predictors of treatment remission in late-life depression..
29:2266-2271.
2004
-
Does prenatal nicotine exposure sensitize the brain to nicotine-induced neurotoxicity in adolescence?.
29:1440-1450.
2004
-
Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal..
29:879-890.
2004
-
Left orbital frontal cortex volume and performance on the benton visual retention test in older depressives and controls..
28:2179-2183.
2003
-
Magnetic seizure therapy improves mood in refractory major depression..
28:2045-2048.
2003
-
Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds..
28:1935-1949.
2003
-
Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy..
28:1852-1865.
2003
-
Serotonin-related gene polymorphisms and central nervous system serotonin function..
28:533-541.
2003
-
Olanzapine and clozapine increase the GABAergic neuroactive steroid allopregnanolone in rodents..
28:1-13.
2003
-
Dextroamphetamine modulates the response of the human amygdala..
27:1036-1040.
2002
-
Nicotine decreases bradykinesia-rigidity in haloperidol-treated patients with schizophrenia..
27:684-686.
2002
-
Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats..
27:534-541.
2002
-
Enhancing the technology of clinical trials and the trials model to evaluate newly developed, targeted antidepressants..
27:319-328.
2002
-
Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome..
25:713-728.
2001
-
Subtypes of mania determined by grade of membership analysis..
25:373-383.
2001
-
Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline..
25:131-138.
2001
-
Sex differences in cocaine-stimulated motor behavior: disparate effects of gonadectomy..
25:118-130.
2001
-
Clinician, parent, and child prediction of medication or placebo in double-blind depression study..
23:591-594.
2000
-
Hippocampal remodeling and damage by corticosteroids: implications for mood disorders..
21:474-484.
1999
-
Effects of fluoxetine on the polysomnogram in outpatients with major depression..
20:447-459.
1999
-
Adrenergic receptor function in panic disorder. I. Platelet alpha 2 receptors: Gi protein coupling, effects of imipramine, and relationship to treatment outcome..
20:162-176.
1999
-
Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?.
19:434-444.
1998
-
Gender difference in cocaine-induced HPA axis activation..
16:399-407.
1997
-
Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia..
15:587-594.
1996
-
Nicotine-haloperidol interactions and cognitive performance in schizophrenics..
15:429-436.
1996
-
MAOIs in the contemporary treatment of depression..
12:185-219.
1995
-
Fluoxetine and oculomotor activity during sleep in depressed patients..
12:159-165.
1995
-
The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study..
10:85-91.
1994
-
The effects of nefazodone on sleep architecture in depression..
10:123-127.
1994
-
Plasma homovanillic acid and performance on motor and cognitive tasks in community-dwelling elderly: MacArthur studies of successful aging..
10:29-35.
1994
-
CATECHOLAMINE RECEPTORS - MOLECULAR CHARACTERIZATION AND PHYSIOLOGICAL IMPLICATIONS.
9:S35-S36.
1993
-
Low plasma GABA is a trait-like marker for bipolar illness..
9:125-132.
1993
-
Cellular regulation of the benzodiazepine/GABA receptor: arachidonic acid, calcium, and cerebral ischemia..
6:119-125.
1992
-
Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity..
4:87-93.
1991
-
Effects of propranolol on cardiovascular and neuroendocrine responses to mental arithmetic in type A men..
1:337-340.
1988
-
Reduced rapid eye movement latency. A predictor of recurrence in depression..
1:33-39.
1987
-
Probing Disparities in Exposure to Smoking Contexts Using Computer Vision
2022
-
Amplification of the Effects of Adolescent Binge Alcohol Exposure by Pretreatment With an Alpha-7 Nicotinic Receptor Positive Allosteric Modulator
2021
-
Antidepressant Response of Electroconvulsive Therapy and Magnetic Seizure Therapy: Response Trajectories by Symptom Clusters
2021
-
Baseline Memory Function Affects Memory Outcome in Older Adults With Major Depressive Disorder Treated With Acute Course Electroconvulsive Therapy and Venlafaxine
2021
-
Developing Novel Treatments for Psychiatric Illnesses: Can Drug Development Tool Qualification Advance CNS Drug Development?
2021
-
Translational Drug Development for Pediatric CNS Disorders
2021
-
Acute Effects of Electroconvulsive Therapy and Venlafaxine on Verbal Learning and Memory Dimensions in Older Adults With Major Depressive Disorder
2020
-
Aggression: Gaps in our Knowledge and Strategies to Enhance Research in the Field
2020
-
BI 425809 Once Daily in Patients With Schizophrenia: Feasibility of Novel Endpoints to Assess Motivation
2020
-
Embedded Temporal Patterns in the Feedback Signal Differentially Predict VTA Neurofeedback-Mediated Learning to Self-Regulate Motivation
2020
-
Exposure to Smoking Context Potentiates Habitual Motor Response
2020
-
Impact of Daily Caffeine on Actigraphically-Measured Sleep Duration Among Adolescents With and Without Attention-Deficit/Hyperactivity Disorder
2020
-
Neural Correlates of Social Reward Processing Differ Between Young Adult Smokers and Non-Smokers
2020
-
Sex Differences in Conditioned Taste Aversion
2020
-
Androsterone and DHEAS are Inversely Associated With Pain Symptoms in Male Iraq/Afghanistan-Era Veterans
2019
-
Associations Between Sleep, Neurocognitive Performance, and ADHD Symptom Severity Among Adolescents
2019
-
Neural Mechanisms Underlying Effects of Propranolol on Drug Cue Reactivity
2019
-
Neuropsychopharmacology (NPP) Special Projects: Update on Gender Balance in NPP Function and Examination of Relationships Between Social Media and Citation Counts
2019
-
Neurosteroids in TBI: Biomarkers to Therapeutics
2019
-
Artificial Intelligence as a Transformative Force for Research and Practice in Neuropsychiatric Disorders: A Realistic Aspiration or a Magical Fantasy?
2019
-
Cognitive Control Across the Spectrum of Major Depressive Disorder
2019
-
Online Repetitive Transcranial Magnetic Stimulation Enhances Working Memory Performance in Younger and Older Adults
2018
-
Rapastinel, a Nonopioid Pharmacotherapy for Opioid Dependence?
2018
-
Real-Time fMRI as a CBT Adjunct: Predicting the Behavioral Impact of Neurofeedback
2018
-
Informing the Complex Association Between Depression Symptom Severity and Neurocognitive Function in Geriatric Major Depressive Disorder
2018
-
Biomarkers and New Therapeutics in TBI and PTSD: Neurosteroid Signatures to Phase II Randomized Controlled Trials
2017
-
Conditioned Food Avoidance in Adolescence: A Contributor to Eating Disorders?
2017
-
Delta-9-Tetrahydrocannabinol Exposure Alters Sperm Methylation Profiles: Concurrent Results From Humans and Rats
2017
-
Increased Activation in Precuneus and Parahippocampus When Smokers View Tobacco Retail Outlets: Results of a GPS plus fMRI 'Community Neuroscience' Study
2017
-
Meta-Analysis of DNA Methylation and PTSD in the Psychiatric Genomics Consortium PTSD Epigenetics Workgroup
2017
-
Phase I Open Label Trial of Autologous Cord Blood for Treatment of Autism: Correlations Between Behavioral Improvement and Increased White Matter Connectivity in Children With Autism
2017
-
fMRI- and Computationally-Guided rTMS Enhances Performance in Working Memory Manipulation
2017
-
Electric Field Characteristics of Low-Field Synchronized Transcranial Magnetic Stimulation (sTMS)
2017
-
Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy and Pharmacotherapy in Geriatric Major Depressive Disorder
2017
-
ADHD, Smoking Withdrawal, and Resting State Functional Connectivity: Results of a fMRI Study With Methylphenidate Challenge
2016
-
Cognitive Neurostimulation of the Dopamine System
2016
-
How Do Astrocytes Shape Synaptic Circuits?
2016
-
Initial Response to Intranasal Nicotine Young Adults With and Without Attention Deficit Hyperactivity Disorder
2016
-
Neurocognitive Effects of Combined Electroconvulsive Therapy and Venlafaxine in Elderly Adults With Major Depressive Disorder
2016
-
Adenosine Regulation of Dopamine Release and Behavior in Adolescent Rats
2015
-
Comparing the Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Quality of Life
2015
-
Ethanol Withdrawal in Adolescent and Adult Rats
2015
-
From Good Habit to Bad: Corticostriatal Synaptic and Circuit Mechanisms in Habit and Compulsion
2015
-
Posttraumatic Stress Disorder and Common Genetic Variants Affect Subcortical Brain Volumes in Recent Military Veterans
2015
-
Connectivity Analysis of Eeg in Depressed Patients Receiving Electroconvulsive Therapy and Magnetic Seizure Therapy
2015
-
A Pharmacogenetics Supported Clinical Trial to Delay Onset of Mild Cognitive Impairment due to Alzheimer's Disease Using Low Dose Pioglitazone: The Tommorrow Study
2014
-
Dasotraline as a Novel DAT/NET Inhibitor for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-concept Trial in Adults
2014
-
Ethanol Withdrawal in Adolescent and Adult Rat
2014
-
Neuroserpin Protects Parvalbumin Interneurons Against Perineuronal Net Degradation for Cortical Stability
2014
-
The Influence of APOE Genotype on Aging's Effect on Brain Structure and Cognition in Younger Adults with and without Depression
2014
-
Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression
2014
-
Lesions of the Orbitofrontal Cortex Reduce Risk-taking in Rats
2014
-
The Differential Effects of an Index Course of Magnetic Seizure Therapy and Electroconvulsive Therapy on Autobiographical Memory Specificity
2014
-
Independent Effects of Lps and Social Isolation on Forced Swim Behavior in Female Mice
2013
-
Insights into the Roles of the Methyl-DNA Binding Protein MeCP2 in Addictive-like Behaviors
2013
-
MDPV Has Potent and Atypical Effects on Dopamine Release in Adolescent and Adult Rats
2013
-
Neurosteroids as Novel Therapeutics and Biomarker Candidates in Schizophrenia and PTSD
2013
-
Rapid Reduction in Suicide Risk in Depressed Elderly Treated with Electroconvulsive Therapy (ECT): Data from Phase I of the PRIDE Study
2013
-
A preliminary metabolomic analysis of older adults with and without depression
2006
-
Bupropion reinstates cocaine seeking behavior in rats
2006
-
Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: Candidate mechanism for superior efficacy?
2006
-
Decisional competence to complete psychiatric advance directives
2006
-
Effects of 24 hour smoking abstinence on sustained and event-related brain activity during continuous working memory: Preliminary results of an fMRI study
2006
-
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial
2006
-
Pregnenolone alterations in parietat cortex are associated with death by suicide in patients with schizophrenia
2006
-
Sodium oxybate for the treatment of fibromyalgia: A double-blind, placebo-controlled trial
2006
-
Transcranial magnetic stimulation: Effectiveness and safety in a randomized, controlled, multisite clinical trial and an open-label extension study
2006
-
cTMS: A novel TMS device inducing near rectangular pulses with controllable pulse width
2006
-
5HTTLPR genotypes and environmental stress interact to affect sleep quality
2005
-
A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with oros methylphenidate in treatment resistant depression
2005
-
Candidate gene polymorphisms and birth weight (BW) in the national longitudinal study of adolescent health (add health)
2005
-
Clozapine effects on memory function are reversed by hippocampal damage
2005
-
Deficit in the GABAergic neuroactive steroid allopregnanolone in Alzheimer's dementia and relevance to neuropathological disease stage: Investigations in temporal cortex
2005
-
Serotonin transporter polymorphism influences the prolactin response to tryptophan and stress
2005
-
The impact of infection early in life on the formation of long-term memories in adulthood
2005
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: Primary efficacy and safety outcomes of the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial
2005
-
Randomized controlled trial of the cognitive side effects of magnetic seizure therapy and electroconvulsive shock
2005
-
Effects of treatment with a cyclic peptide that targets PDZ domain of PSD-95: Peptide administration to the ventral tegmental area inhibits opiate-induced motor sensitization in C57BL/6 mice
2004
-
Neuroactive steroid alterations in schizophrenia and bipolar disorder: A negative ion chemical ionization gas chromatography/mass spectrometry investigation in posterior cingulate
2004
-
Neuroactive steroids in Alzheimer's disease: Investigations in prefrontal cortex
2004
-
Plasma amyloid beta 1-42 levels in geriatric depression: A pilot study
2004
-
The neuroactive steroid dehydroepiandrosterone sulfate (DHEAS) predicts nicotine dependence severity
2004
-
Electroconvulsive therapy increases angiogenesis and neurogenesis in the monkey hippocampus
2004
-
Neurocognitive function in individuals "at-risk" for psychosis
2004
-
Neuroendocrine response to magnetic seizure therapy (MST) in major depression: Comparison with electroconvulsive therapy
2004
-
Transcranial magnetic stimulation (TMS) in the treatment of resistant Obsessive-Compulsive Disorder (OCD): Clinical outcomes and neurophysiological correlates
2004